Interleukin-1 polymorphisms associated with increased risk of gastric cancer
By E. El-Omar, M. Carrington, W. Chow, K. McColl, J. Bream, H. Young, Jesus Herrera, J. Lissowska, Chiu-Chin Yuan, N. Rothman and 4 more. Nature, 2000
2,466 citations recorded by the source corpus.
Subfields: Biomaterials, Immunology, Surgery
View Paper: https://www.semanticscholar.org/paper/da7e217ead64c3e888e6925740ef75a4748e6726
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Surgery
Citations in the corpus
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report (2006, background): “Furthermore, host genetic factors may determine disease outcome 52 The association with H pylori pathogenic factors and host genetic factors is real in Western populations, but the limited strength of the association does not allow a reliable prediction of the outcome at an individual level.”
- Cancer burden in the year 2000. The global picture. (2001, positive): “pylori—a recent study has shown that interleukin-1 gene cluster polymorphisms are associated with an increased risk of gastric cancer [116].”
- The balance between IL-1 and IL-1Ra in disease. (2002, background): “[217] El-Omar EM, Carrington M, Chow W-H, et al.”
- Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy (2022, background): “The development of gastritis and gastric tumor have been linked to genetic polymorphisms in the IL-1β gene.(314) An additional mechanism underlying the increased risk of gastric cancer associated with IL-1β is its ability to induce aberrant DNA methylation.”
- Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk (2010, result): “pylori-colonized persons with high-expression IL-1 polymorphisms have a significantly increased risk for hypochlorhydria, gastric atrophy, and distal gastric adenocarcinoma compared to that for persons with genotypes that limit IL-1 expression (82).”